S A Burchill

948 total citations
14 papers, 760 citations indexed

About

S A Burchill is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S A Burchill has authored 14 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S A Burchill's work include Neuroblastoma Research and Treatments (6 papers), Virus-based gene therapy research (3 papers) and Molecular Biology Techniques and Applications (3 papers). S A Burchill is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Virus-based gene therapy research (3 papers) and Molecular Biology Techniques and Applications (3 papers). S A Burchill collaborates with scholars based in United Kingdom, United States and Italy. S A Burchill's co-authors include Peter J. Selby, Jennifer Southgate, K. Pittman, Brendan Smith, Richard D Riley, Paul C. Lambert, Keith R. Abrams, David Heney, Alex J. Sutton and David R. Jones and has published in prestigious journals such as Oncogene, British Journal of Cancer and Annals of Oncology.

In The Last Decade

S A Burchill

14 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S A Burchill United Kingdom	13	302	299	185	135	132	14	760
Ladan Fazlollahi United States	9	395 1.3×	324 1.1×	373 2.0×	108 0.8×	269 2.0×	21	1.2k
Diana O. Treaba United States	14	179 0.6×	394 1.3×	151 0.8×	103 0.8×	147 1.1×	51	774
D Aldovini Italy	13	293 1.0×	337 1.1×	177 1.0×	41 0.3×	98 0.7×	31	940
Satoshi Amada Japan	21	402 1.3×	276 0.9×	119 0.6×	48 0.4×	155 1.2×	38	1.5k
Peter Lim Canada	16	172 0.6×	316 1.1×	138 0.7×	53 0.4×	145 1.1×	32	1.5k
Tsui‐Lien Mao Taiwan	14	500 1.7×	321 1.1×	188 1.0×	25 0.2×	161 1.2×	24	1.0k
Viera Nelson United States	9	176 0.6×	195 0.7×	98 0.5×	44 0.3×	117 0.9×	10	797
M. Testi Italy	19	289 1.0×	244 0.8×	67 0.4×	63 0.5×	296 2.2×	62	983
Philip A. Branton United States	16	299 1.0×	672 2.2×	263 1.4×	81 0.6×	242 1.8×	24	1.2k
Kenji Yorita Japan	14	260 0.9×	202 0.7×	126 0.7×	34 0.3×	160 1.2×	72	689

Countries citing papers authored by S A Burchill

Since Specialization

Citations

This map shows the geographic impact of S A Burchill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Burchill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Burchill more than expected).

Fields of papers citing papers by S A Burchill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Burchill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Burchill. The network helps show where S A Burchill may publish in the future.

Co-authorship network of co-authors of S A Burchill

This figure shows the co-authorship network connecting the top 25 collaborators of S A Burchill. A scholar is included among the top collaborators of S A Burchill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S A Burchill. S A Burchill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Burchill, S A, et al.. (2013). Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT. British Journal of Cancer. 109(1). 195–206. 12 indexed citations

White, Danielle E. & S A Burchill. (2010). Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours. British Journal of Cancer. 103(9). 1380–1390. 18 indexed citations

Viprey, Virginie, Maria Łastowska, Maria Valeria Corrias, et al.. (2008). Minimal disease monitoring by QRT–PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials. The Journal of Pathology. 216(2). 245–252. 34 indexed citations

Łastowska, Maria, Virginie Viprey, Mauro Santibanez‐Koref, et al.. (2007). Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene. 26(53). 7432–7444. 76 indexed citations

Riley, Richard D, Keith R. Abrams, Alex J. Sutton, et al.. (2003). Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. British Journal of Cancer. 88(8). 1191–1198. 116 indexed citations

Burchill, S A. (2003). Micrometastases in neuroblastoma: are they clinically important?. Journal of Clinical Pathology. 57(1). 14–20. 23 indexed citations

Merrick, Alison, et al.. (2003). FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. British Journal of Cancer. 89(7). 1276–1284. 20 indexed citations

Burchill, S A, et al.. (2002). Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells. British Journal of Cancer. 86(1). 102–109. 23 indexed citations

Berry, Paul A., et al.. (2001). Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells. Medical and Pediatric Oncology. 36(1). 142–146. 2 indexed citations

10.

Burchill, S A, et al.. (1998). Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. British Journal of Cancer. 78(9). 1141–1146. 17 indexed citations

11.

Burchill, S A, John Wheeldon, C. Cullinane, & Ian Lewis. (1997). EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma. European Journal of Cancer. 33(2). 239–243. 41 indexed citations

12.

Keilholz, Ulrich, et al.. (1997). Polymerase chain reaction detection of circulating tumour cells. EORTC Melanoma Cooperative Group, Immunotherapy Subgroup.. PubMed. 7 Suppl 2. S133–41. 14 indexed citations

13.

Pittman, K., et al.. (1996). Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Annals of Oncology. 7(3). 297–301. 67 indexed citations

14.

Burchill, S A, et al.. (1995). Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. British Journal of Cancer. 71(2). 278–281. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact